Lead sponsor
MindRank AI Ltd
6 GLP-1 and incretin trials led. Source: ClinicalTrials.gov, as of July 1, 2026.
6
Trials led
6
Active
1,253
Total enrollment
56
Sites
Distinct sites across this sponsor's lead trials. A site running several of them counts once, matching the map. Total enrollment sums each trial's reported enrollment, whether planned or actual.
Portfolio
How this sponsor's trials break down
Trials by phase
Phase 1
3
Phase 1/2
1
Phase 2
1
Phase 3
1
Trials by status
Not yet recruiting
5
Recruiting
1
Trials led
TrialKey I/E criterionPhaseStatusEnrollment
A Phase III Study to Evaluate the Efficacy and Safety of MDR-001 in Adult Participants With Overweight or Obesity (MOBILE）BMI ≥28Ph 3Not yet recruiting738
A Study to Evaluate the Efficacy and Safety of MDR-001 in Subjects Who Are Obesity or OverweightHbA1c ≤6.5%Ph 2Not yet recruiting300
A Phase I/IIa Clinical Study to Assess the Single and Multiple Ascending Doses of MDR-001 Tablets in Healthy Participants and Obese/ Overweight ParticipantsBMI ≤45Ph 1/2Recruiting131
Pharmacokinetics and Safety of MDR-001 in Mild and Moderate Hepatic ImpairmentBMI 18-32Ph 1Not yet recruiting32
Drug-Drug Interaction Study of MDR-001 With Rifampin and Itraconazole in Healthy Adult ParticipantsBMI 18-28Ph 1Not yet recruiting28
Phase Ib Clinical Study on the Efficacy and Safety of MDR-001 in Patients Who Are Obesity or OverweightBMI ≥28Ph 1Not yet recruiting24